Rapporto sull’analisi delle dimensioni e delle quote del mercato delle immunoterapie allergiche | Previsioni 2031

  • Report Code : TIPRE00008219
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 149
Buy Now

Il mercato delle immunoterapie allergiche è stato valutato a 1.819,18 milioni di dollari nel 2019 e si prevede che raggiungerà 4.185,89 milioni di dollari entro il 2027; si prevede che crescerà a un CAGR dell'11,1% dal 2020 al 2027.

L'immunoterapia allergica, chiamata anche desensibilizzazione o iposensibilizzazione, è un trattamento medico focalizzato su diversi tipi di allergie. Si registra un aumento della prevalenza delle allergie e gli interventi terapeutici convenzionali, come la farmacoterapia, si sono spesso rivelati inefficaci. Di conseguenza, l’immunoterapia allergica sta diventando sempre più popolare per curare diversi tipi di allergie aumentando la tolleranza immunologica e modificando il decorso della malattia. Si prevede che il mercato delle immunoterapie allergiche crescerà a causa di fattori chiave come la crescente prevalenza di disturbi allergici e i progressi tecnologici nelle formulazioni di dosaggio sublinguale. Tuttavia, gli inconvenienti associati all'uso delle immunoterapie allergiche e le variazioni normative tra le regioni potrebbero ostacolare la crescita del mercato durante il periodo di previsione.

Regioni redditizie per le immunoterapie allergiche Mercato


Approfondimenti strategici

Approfondimenti di mercato

Crescente prevalenza dei disturbi allergici< /p>

I disturbi allergici sono i problemi più comuni affrontati dai medici di base e dai pediatri; più del 25% della popolazione nei paesi sviluppati soffre di allergie. Le allergie comprendono uno spettro di disturbi caratterizzati dallo sviluppo di una risposta immunitaria iperattiva a un allergene, con conseguente risposta di citochine polarizzate Th2 all'allergene e la produzione di una risposta anticorpale IgE.

< p>La crescente prevalenza dei disturbi allergici richiede l'immunoterapia allergica, che è un trattamento sicuro ed efficace contro allergeni come pollini, muffe di insetti e animali, nonché contro l'asma allergica. Nel recente rapporto del National Health and Nutrition Examination Survey, il 54% della popolazione ha avuto risposte positive ai test per uno o più allergeni. Secondo l'American Academy of Allergy, Asthma & In immunologia, la rinite allergica colpisce il 10-30% della popolazione e le reazioni avverse ai farmaci possono colpire fino al 10% della popolazione globale e quasi il 20% dei pazienti ospedalizzati. Secondo i dati dell'indagine del Centro nazionale per le statistiche sanitarie condotta nel 2018, il numero di allergie respiratorie, allergie alimentari e allergie cutanee segnalate negli ultimi 12 mesi è stato rispettivamente di 7,1 milioni, 4,8 milioni e 9,2 milioni.

L'immunoterapia è un trattamento preventivo per le reazioni allergiche a sostanze come gli acari della polvere domestica, il veleno d'api e i pollini delle erbe. L’immunoterapia prevede un aumento graduale delle dosi dell’allergene o della sostanza a cui il paziente è allergico. Le dosi incrementali dell'allergene fanno sì che il sistema immunitario diventi meno sensibile alla sostanza, probabilmente inducendo la produzione di un anticorpo “bloccante”; questo riduce i sintomi allergici quando la sostanza viene incontrata in futuro. L’immunoterapia riduce anche l’infiammazione che caratterizza l’asma e la rinite. I disturbi allergici sono per lo più trattati con l’immunoterapia; pertanto, la crescente prevalenza delle malattie allergiche guida la crescita del mercato.

Approfondimenti basati sul trattamento

Il mercato globale delle immunoterapie per le allergie, basato sul trattamento, è segmentato in immunoterapia sottocutanea (SCIT) e immunoterapia sublinguale (SLIT). Nel 2019, il segmento dell'immunoterapia sottocutanea (SCIT) deteneva la quota maggiore del mercato, per trattamento. Tuttavia, si prevede che il segmento dell'immunoterapia sublinguale (SLIT) crescerà al ritmo più rapido durante il periodo di previsione.

           ;          '   ;          '   ;          '   ;

Mercato globale delle immunoterapie per le allergie, per trattamento– 2019 e 2027

Approfondimenti basati sul tipo di allergia

Il mercato globale delle immunoterapie per l'allergia, in base al tipo di allergia, è stato segmentato in rinite allergica, asma, allergia alimentare, allergia al veleno, e altri. Il segmento della rinite allergica ha detenuto la quota più elevata del mercato delle immunoterapie allergiche nel 2019, per tipo di allergia. Inoltre, si prevede che lo stesso segmento assisterà a una crescita a un ritmo significativo durante il periodo di previsione, dal 2020 al 2027.

Approfondimenti basati sul canale di distribuzione

Il mercato globale delle immunoterapie allergiche, in base al canale di distribuzione, è segmentato in farmacia ospedaliera, farmacia al dettaglio e farmacia online. Nel 2019, il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato, per canale di distribuzione. Inoltre, si prevede che lo stesso segmento farmaceutico crescerà al ritmo più rapido durante il periodo di previsione

I lanci di prodotto e la strategia di espansione sono comunemente adottati dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Queste strategie sono comunemente adottate dagli operatori del mercato al fine di espandere il proprio portafoglio di prodotti.

Gli operatori del mercato che operano nel mercato delle immunoterapie allergiche hanno adottato la strategia dell'innovazione del prodotto per soddisfare i cambiamenti dei clienti domanda in tutto il mondo, il che consente anche ai giocatori di mantenere il proprio marchio a livello globale.

Per trattamento

  • Immunoterapia sottocutanea (SCIT)
  • Immunoterapia sublinguale (SLIT)

Per tipo di allergia

  • Rinite allergica
  • Asma
  • Allergia alimentare
  • Allergia al veleno
  • Altro

Per canale di distribuzione

  • Farmacia ospedaliera
  • Farmacia al dettaglio
  • Farmacia online

Per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • Europa
    • Francia
    • Germania
    • < li>Italia
    • Regno Unito
    • Spagna
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
  • Medio Oriente e Stati Uniti. Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
  • Sudamerica (SAM)< ul>
  • Brasile
  • Argentina

Profili aziendali

  • ALK-Abelló A/S
  • AIMMUNE THERAPEUTICS, INC.
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy BV
  • Johnson e Johnson Services, Inc.
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Allergy Therapeutics
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the allergy immunotherapies market?

The allergy immunotherapy market majorly consists of the players such as ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V., Anergis, DBV Technologies, Dermapharm Holding, Allergy Therapeutics, ASIT biotech are among others.

What are the driving factors for the allergy immunotherapies market across the globe?

The factors that are driving the growth of the market are increasing prevalence of allergic disorders and rising preference for immunotherapies due to efficacy and cost-effectiveness are expected to boost the growth of the global allergy immunotherapy market.

What is allergy Immunotherapy?

Allergy Immunotherapy is an allergy treatment process that involves administering small quantities of allergens into your body and then building up doses slowly over some time until the patient develops immunity. Two types of immunotherapy therapies are available in the market, such as subcutaneous immunotherapy (SCIT), also called allergy shots, and sublingual immunotherapy (SLIT). Individuals with symptoms of allergy and do not respond to conventional medical treatments are the potential targets for allergen immunotherapy.

The List of Companies - Allergy Immunotherapies Market

  1. ALK-Abelló A/S
  2. AIMMUNE THERAPEUTICS, INC.
  3. LETIPharma
  4. Stallergenes Greer
  5. HAL Allergy B.V.
  6. Johnson and Johnson Services, Inc.
  7. Anergis
  8. DBV Technologies
  9. Dermapharm Holding
  10. Allergy Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports